A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314)
| Image |  |
|---|---|
| Description | scientific article published on 02 May 2018 |
| Author/s |
author: Rachel Rau Eric S Schafer |
| Publication date | May 2, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |